Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Targeted Video Messaging About Emergency Contraception

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03774368
Recruitment Status : Completed
First Posted : December 13, 2018
Last Update Posted : July 16, 2019
Sponsor:
Information provided by (Responsible Party):
Planned Parenthood League of Massachusetts

Brief Summary:
This research study will assess the real-world effectiveness of Facebook advertising as a strategy to reach women of reproductive age who are at risk of unintended pregnancy with a brief educational intervention about emergency contraception (EC).

Condition or disease Intervention/treatment Phase
Contraception Other: Emergency contraception website Other: Emergency contraception video Not Applicable

Detailed Description:
This research study will assess the real-world effectiveness of Facebook advertising as a strategy to reach women of reproductive age who are at risk of unintended pregnancy with a brief educational intervention about emergency contraception (EC). The investigators will assess whether a video or website link has superior reach, engagement, and return on investment (measured as cost per click) through a Facebook ad campaign. The investigators will also ensure that both modalities of consumer engagement (website and video) are efficacious at ensuring adequate and improved knowledge of emergency contraception through a laboratory-environment trial.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 150 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Targeted Video Messaging About Emergency Contraception Via a Social Media Platform
Actual Study Start Date : January 15, 2019
Actual Primary Completion Date : June 7, 2019
Actual Study Completion Date : June 7, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Birth Control

Arm Intervention/treatment
Website about emergency contraception
Subjects are randomly assigned to view an existing website about emergency contraception. The website contains information about the three methods of emergency contraception: the copper IUD, ulipristal pill, and levonorgestrel pill. It includes information about their relative effectiveness and where to access emergency contraception.
Other: Emergency contraception website
Existing website with factual information about emergency contraception

Video about emergency contraception
Subjects are randomly assigned to view an existing video about emergency contraception. The video is two minutes in length and contains information about the three methods of emergency contraception: the copper IUD, ulipristal pill, and levonorgestrel pill. It includes information about their relative effectiveness and where to access emergency contraception.
Other: Emergency contraception video
Existing video with factual information about emergency contraception




Primary Outcome Measures :
  1. Emergency contraception knowledge (binary) [ Time Frame: Immediately after intervention ]
    This outcome is a binary outcome that reflects a participant's ability to correctly identify an emergency contraceptive method, when to use it, and how to access it


Secondary Outcome Measures :
  1. Copper IUD as emergency contraception knowledge [ Time Frame: Immediately after intervention ]
    This outcome is a binary outcomes that reflects a participant's ability to correctly identify the copper IUD as emergency contraception, when to use it, and how to access it.

  2. Levonorgestrel pill as emergency contraception knowledge [ Time Frame: Immediately after intervention ]
    This outcome is a binary outcomes that reflects a participant's ability to correctly identify the levonorgestrel pill as emergency contraception, when to use it, and how to access it.

  3. Ulipristal pill as emergency contraception knowledge [ Time Frame: Immediately after intervention ]
    This outcome is a binary outcomes that reflects a participant's ability to correctly identify the ulipristal pill as emergency contraception, when to use it, and how to access it.

  4. Emergency contraception knowledge (continuous) [ Time Frame: Immediately after intervention ]
    This outcome reflects the participant's overall knowledge of emergency contraception after the website or video intervention, as measured by the proportion of questions they get correct on the survey

  5. Change in emergency contraception knowledge pre- and post-intervention [ Time Frame: Immediately before and immediately after intervention ]
    This outcome reflects the participant's change in knowledge of emergency contraception before and after the website or video intervention, as measured by the proportion of questions they get correct on the survey.

  6. Likelihood of using emergency contraception pre- and post-intervention [ Time Frame: Immediately before and immediately after intervention ]
    This outcome reflects the participant's likelihood of using emergency contraception both before and after the intervention, as measured on a 6 point likert scale (I would definitely use it, Very likely, Somewhat likely, Somewhat unlikely, Very unlikely, I definitely would NOT use it)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 29 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Women
  • 18 to 29 years old
  • Living or seeking care in or around Boston, MA
  • Able to participate in an in-person visit at Planned Parenthood League of Massachusetts (PPLM) Boston Health Center
  • English fluency
  • Have at least one social media account (i.e. Facebook, Instagram, Twitter, Pinterest, YouTube, Snapchat)
  • Endorse using social media at least once a week

Exclusion Criteria:

  • PPLM staff
  • Currently or ever employed in the reproductive health field
  • Currently using long-acting reversible contraception (LARC)
  • History of permanent sterilization (by participant or sexual partner)
  • Previous participation in the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03774368


Locations
Layout table for location information
United States, Massachusetts
PPLM
Boston, Massachusetts, United States, 02215
Sponsors and Collaborators
Planned Parenthood League of Massachusetts
Investigators
Layout table for investigator information
Principal Investigator: Principal Investigator, MD Planned Parenthood League of Massachusetts
Layout table for additonal information
Responsible Party: Planned Parenthood League of Massachusetts
ClinicalTrials.gov Identifier: NCT03774368    
Other Study ID Numbers: 2018P001764
First Posted: December 13, 2018    Key Record Dates
Last Update Posted: July 16, 2019
Last Verified: July 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Emergencies
Disease Attributes
Pathologic Processes